Gestational trophoblastic disease

Blagden, 2002, The effect of early pregnancy following chemotherapy on disease relapse and fetal outcome in women treated for gestational trophoblastic tumours, Br J Cancer, 86, 26, 10.1038/sj.bjc.6600041 Cole, 1998, Phantom HCG and phantom choriocarcinoma, Gynecol Oncol, 71, 325, 10.1006/gyno.1998.5181 1997 McNeish, 2002, Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000, J Clin Oncol, 20, 1838, 10.1200/JCO.2002.07.166 Newlands ES, Bagshawe KID, Begent RHJ, Rustin GJS, Holden L, Results with the EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high-risk gestational trophoblastic tumours, 1979–1989, Br J Obstet Gynaecol 1991;98:550–55Z. Ngan, 2002, FIGO staging and risk factor scoring for trophoblastic neoplasia, Int J Obstet Gynecol, 77, 285 Papadopoulos, 2002, Twenty-five years’ clinical experience with placental site trophoblastic tumors, J Reprod Med, 47, 460 Paradinas, 1997, Pathology in gestational trophoblastic disease, 43 Sebire, 2002, Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin, Lancet, 359, 2165, 10.1016/S0140-6736(02)09085-2 Shih, 2002, Molecular basis of gestational trophoblastic diseases, Curr Mol Med, 2, 1, 10.2174/1566524023362960